Ponesimod Tablets 20 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg
Reference Brands: Ponvory(US & EU)
Category: Multiple sclerosis
Ponesimod is a selective sphingosine-1-phosphate receptor modulator that prevents lymphocyte migration, reducing neuroinflammation. It decreases relapse rates and slows disease progression in multiple sclerosis. Benefits include oral dosing, targeted immune regulation, reduced relapse frequency, and improved quality of life for patients with relapsing MS.
Product Description:
Ponesimod, marketed as Gilyea, is approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis (MS). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves comprehensive analysis of clinical trial results and manufacturing standards, while the EMA ensures compliance with regional safety and quality regulations.
Ponesimod Tablets — third party manufacturing & bulk supply
Ponesimod Tablets 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Ponesimod Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ponesimod Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ponesimod Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
